Literature DB >> 22419692

Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis.

Behzad Ebrahimi1, Zilun Li, Alfonso Eirin, Xiang-Yang Zhu, Stephen C Textor, Lilach O Lerman.   

Abstract

Renal artery stenosis (RAS) promotes microvascular rarefaction and fibrogenesis, which may eventuate in irreversible kidney injury. We have shown that percutaneous transluminal renal angioplasty (PTRA) or endothelial progenitor cells (EPC) improve renal cortical hemodynamics and function in the poststenotic kidney. The renal medulla is particularly sensitive to hypoxia, yet little is known about reversibility of medullary injury on restoration of renal blood flow. This study was designed to test the hypothesis that PTRA, with or without adjunct EPC delivery to the stenotic kidney, may improve medullary remodeling and tubular function. RAS was induced in 21 pigs using implantation of irritant coils, while another group served as normal controls (n = 7 each). Two RAS groups were then treated 6 wk later with PTRA or both PTRA and EPC. Four weeks later, medullary hemodynamics, microvascular architecture, and oxygen-dependent tubular function of the stenotic kidneys were examined using multidetector computed tomography, microcomputed tomography, and blood oxygenation level-dependent MRI, respectively. Medullary protein expression of vascular endothelial growth factor, endothelial nitric oxide synthase, hypoxia-inducible factor-1α, and NAD(P)H oxidase p47 were determined. All RAS groups showed decreased medullary vascular density and blood flow. However, in RAS+PTRA+EPC animals, EPC were engrafted in tubular structures, oxygen-dependent tubular function was normalized, and fibrosis attenuated, despite elevated expression of hypoxia-inducible factor-1α and sustained downregulation of vascular endothelial growth factor. In conclusion, EPC delivery, in addition to PTRA, restores medullary oxygen-dependent tubular function, despite impaired medullary blood and oxygen supply. These results support further development of cell-based therapy as an adjunct to revascularization of RAS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22419692      PMCID: PMC3378175          DOI: 10.1152/ajprenal.00563.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  29 in total

Review 1.  Renovascular hypertension and ischemic nephropathy.

Authors:  Vesna D Garovic; Stephen C Textor
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT.

Authors:  Elena Daghini; Andrew N Primak; Alejandro R Chade; James D Krier; Xiang-Yang Zhu; Erik L Ritman; Cynthia H McCollough; Lilach O Lerman
Journal:  Radiology       Date:  2007-05       Impact factor: 11.105

Review 3.  Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2005-11-16       Impact factor: 10.121

Review 4.  Hypoxia of the renal medulla--its implications for disease.

Authors:  M Brezis; S Rosen
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

5.  Noninvasive evaluation of a novel swine model of renal artery stenosis.

Authors:  L O Lerman; R S Schwartz; J P Grande; P F Sheedy; J C Romero
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

6.  Renal artery angioplasty: technical results and clinical outcome in 320 patients.

Authors:  F S Bonelli; M A McKusick; S C Textor; P B Kos; A W Stanson; C M Johnson; P F Sheedy; T J Welch; A Schirger
Journal:  Mayo Clin Proc       Date:  1995-11       Impact factor: 7.616

7.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Authors:  Maja T Lindenmeyer; Matthias Kretzler; Anissa Boucherot; Silvia Berra; Yoshinari Yasuda; Anna Henger; Felix Eichinger; Stefanie Gaiser; Holger Schmid; Maria P Rastaldi; Robert W Schrier; Detlef Schlöndorff; Clemens D Cohen
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

8.  Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension.

Authors:  Marilda Mazzali; J Ashley Jefferson; Zehmin Ni; Nosratola D Vaziri; Richard J Johnson
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

9.  Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress.

Authors:  Xiang-Yang Zhu; Alejandro R Chade; Martin Rodriguez-Porcel; Michael D Bentley; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-12       Impact factor: 8.311

10.  Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)?

Authors:  W Kenneth Ward; Matthew J Quinn; Michael D Wood; Kenneth L Tiekotter; Sudha Pidikiti; Jennifer A Gallagher
Journal:  Biosens Bioelectron       Date:  2003-11-30       Impact factor: 10.618

View more
  23 in total

Review 1.  Renal relevant radiology: renal functional magnetic resonance imaging.

Authors:  Behzad Ebrahimi; Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

Review 2.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 3.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 4.  Novel therapeutic strategies for renovascular disease.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

Review 5.  Challenges and opportunities for stem cell therapy in patients with chronic kidney disease.

Authors:  LaTonya J Hickson; Alfonso Eirin; Lilach O Lerman
Journal:  Kidney Int       Date:  2016-01-26       Impact factor: 10.612

Review 6.  Potential approaches to reverse or repair renal fibrosis.

Authors:  Desiree Tampe; Michael Zeisberg
Journal:  Nat Rev Nephrol       Date:  2014-02-11       Impact factor: 28.314

7.  Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Amrutesh S Puranik; Hui Tang; Kelly A McGurren; Andre J van Wijnen; Amir Lerman; Lilach O Lerman
Journal:  Kidney Int       Date:  2017-02-24       Impact factor: 10.612

8.  Cell-Based Therapies as an Adjunct to Revascularization in Experimental Atherosclerotic Reno Vascular Disease.

Authors:  Alfonso Eirin; Behzad Ebrahimi; Lilach O Lerman
Journal:  J Clin Exp Cardiolog       Date:  2012-07-03

9.  Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.

Authors:  Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

10.  Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate.

Authors:  Ahmed Saad; Sandra M S Herrmann; John Crane; James F Glockner; Michael A McKusick; Sanjay Misra; Alfonso Eirin; Behzad Ebrahimi; Lilach O Lerman; Stephen C Textor
Journal:  Circ Cardiovasc Interv       Date:  2013-07-30       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.